Patent Oppositions in form specific drugs industry

Explore the competitive field of form specific drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in form specific drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for form specific drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the form specific drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the form specific drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 9, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the form specific drugs industry

Tablets Comprising Eltrombopag OlamineNOVARTISSep 9, 2025ELKINGTON AND FIFE
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 4, 2025ELKINGTON AND FIFE
Pharmaceutical FormulationsGILEAD SCIENCESSep 4, 2025ELKINGTON AND FIFE
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025SANDOZ
LozengeALTRIA CLIENT SERVICESSep 3, 2025PHILIP MORRIS
Pharmaceutical FormulationsGILEAD SCIENCESSep 3, 2025EIP
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
Excipients For Nicotine-Containing Therapeutic CompositionsMODORAL BRANDSSep 2, 2025PHILIP MORRIS
Pharmaceutical FormulationsGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISSep 1, 2025CAMULON

To stay ahead in the competitive form specific drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the form specific drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 9, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED12
Aug 18, 2021Formulations Of EnzalutamideASTELLAS PHARMA12
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUE11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 5, 2018Apixaban FormulationsPFIZER10
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Oct 16, 2019Apixaban FormulationsPFIZER10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10